Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors

Journal of Psychosomatic Research

Volumn 71, Issue 3, 2011, Pages 136-141

  Orre, Ingrid J ^a   Reinertsen, Kristin V ^b,c   Aukrust, Pål ^d   Dahl, Alv A ^b   Fosså, Sophie D ^b   Ueland, Thor ^d   Murison, Robert ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Anxiety; Breast cancer survivors; Depression; Fatigue; HsCRP; IL 1ra; IL 6; Leukocyte count; Neopterin; STNF R1

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; NEOPTERIN; TAMOXIFEN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CONTROLLED STUDY; DEPRESSION; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; FATIGUE; FEMALE; HUMAN; INSOMNIA; LEUKOCYTE COUNT; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BREAST NEOPLASMS; C-REACTIVE PROTEIN; DEPRESSION; DISEASE-FREE SURVIVAL; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDICAL RECORDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SURVIVORS;

EID: 80051689508     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2011.04.003     Document Type: Article

References (25)

1. Bardwell WA, Ancoli-Israel S Breast cancer and fatigue. Sleep Med Clin 2008 Mar, 3:61-71.
2. Bower JE Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol Feb 10 2008, 26:768-777.
3. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol Feb 20 2008, 26:971-982.
4. Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun May 2007, 21:413-427.
5. Bower JE, Ganz PA, Aziz N, Fahey JL Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002, 64:604-611.
6. Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res May 1 2006, 12:2759-2766.
7. Alexander S, Minton O, Andrews P, Stone P A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer Feb 2009, 45:384-392.
8. Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fossa SD Predictors and course of chronic fatigue in long-term breast cancer survivors. J Cancer Surviv 2010.
9. Landmark-Hoyvik H, Reinertsen KV, Loge JH, Fossa SD, Borresen-Dale AL, Dumeaux V Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J 2009, 9:333-340.
10. Wessely S The epidemiology of chronic fatigue syndrome. Epidemiol Rev 1995, 17:139-151.
11. Pawlikowska T, Chalder T, Hirsch SR, Wallace P, Wright DJ, Wessely SC Population based study of fatigue and psychological distress. BMJ 1994, 308:763-766.
12. Loge JH, Ekeberg O, Kaasa S Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res 1998, 45:53-65.
13. O'Connor MF, Bower JE, Cho HJ, Creswell JD, Dimitrov S, Hamby ME, et al. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun 2009, 23:887-897.
14. Reinertsen KV, Cvancarova M, Wist E, Bjoro T, Dahl AA, Danielsen T, et al. Thyroid function in women after multimodal treatment for breast cancer stage ii/iii: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys 2009.
15. Thorsen L, Nystad W, Stigum H, Dahl O, Klepp O, Bremnes RM, et al. The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Support Care Cancer 2005, 13:637-646.
16. World Health Organization Obesity and overweight. What are overweight and obesity? Available from:. http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
17. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res 1993, 37:147-153.
18. Zigmond AS, Snaith RP The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
19. Sivertsen B, Krokstad S, Overland S, Mykletun A The epidemiology of insomnia: associations with physical and mental health. The HUNT-2 study. J Psychosom Res 2009, 67:109-116.
20. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Oie E, Otterdal K, et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008, 28:1909-1919.
21. Ferrucci L, Ble A, Bandinelli S, Lauretani F, Suthers K, Guralnik JM A flame burning within. Aging Clin Exp Res 2004, 16:240-243.
22. Howren MB, Lamkin DM, Suls J Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
23. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001, 47:426-430.
24. Bower JE, Ganz PA, Tao ML, Hu W, Belin TR, Sepah S, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res 2009, 15:5534-5540.
25. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001, 47:444-450.